share_log

Nektar Therapeutics(NKTR.US) 10% Shareholder Sells US$99,629.6 in Common Stock

moomoo News ·  May 13 17:19

$Nektar Therapeutics (NKTR.US)$ 10% Shareholder Deep Track Capital, LP sold 56,000 shares of common stock on May 10, 2024 at an average price of $1.7791 for a total value of $99,629.6.

This transaction involves other related parties: Deep Track Biotechnology Master Fund, Ltd. and KROIN DAVID.

1715635179754052523.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment